Geneva Advisors’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$11.6M Sell
175,231
-5,479
-3% -$348K 0.2% 87
2017
Q1
$10.8M Sell
180,710
-12,734
-7% -$732K 0.19% 93
2016
Q4
$10.8M Sell
193,444
-19,871
-9% -$1.06M 0.21% 89
2016
Q3
$10.2M Sell
213,315
-179,226
-46% -$10.2M 0.19% 88
2016
Q2
$22.5M Sell
392,541
-3,958
-1% -$239K 0.44% 68
2016
Q1
$24.9M Sell
396,499
-18,405
-4% -$1.07M 0.5% 64
2015
Q4
$24.9M Buy
414,904
+14,232
+4% +$917K 0.48% 65
2015
Q3
$25.1M Buy
400,672
+35,770
+10% +$2.25M 0.51% 63
2015
Q2
$22.3M Sell
364,902
-977
-0.3% -$61.3K 0.4% 72
2015
Q1
$22.8M Buy
365,879
+3,662
+1% +$216K 0.41% 75
2014
Q4
$19.1M Buy
362,217
+49,525
+16% +$2.47M 0.36% 76
2014
Q3
$14M Buy
312,692
+51,703
+20% +$2.43M 0.26% 84
2014
Q2
$12.8M Buy
260,989
+194,700
+294% +$9.49M 0.23% 95
2014
Q1
$3.35M Buy
66,289
+51,597
+351% +$2.58M 0.06% 162
2013
Q4
$742K Hold
14,692
0.01% 285
2013
Q3
$603K Hold
14,692
0.01% 310
2013
Q2
$460K Buy
+14,692
New +$488K 0.01% 290

Other funds holding CTSH

Geneva Advisors's CTSH Position: Q2 2017 in Review

Geneva Advisors reduced its Cognizant (CTSH) stake by 3% in Q2 2017, selling an estimated $348K and leaving 175,231 shares worth $11.6M. The position accounts for 0.2% of the portfolio, ranked #87.

Geneva Advisors first reported a position in CTSH in Q2 2013 and has held it in 17 quarters since. The position peaked at $25.1M in Q3 2015. 875 funds tracked by Wall St. Rank hold CTSH as of Q2 2017.

  • Geneva Advisors held 175,231 shares of Cognizant worth $11.6M as of Q2 2017.
  • Geneva Advisors sold 5,479 Cognizant shares in Q2 2017, an estimated $348K.
  • Cognizant made up 0.2% of Geneva Advisors's portfolio in Q2 2017, its #87 holding.
  • Geneva Advisors first reported a position in Cognizant in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Cognizant position peaked at $25.1M in Q3 2015.
  • 875 funds tracked by Wall St. Rank held Cognizant as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.